• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.95% Nasdaq Down 2.40%

    XOMA Corporation (XOMA)

    -NasdaqGM
    3.66 Down 0.26(6.63%) Jun 29, 4:00PM EDT
    |After Hours : 3.75 Up 0.09 (2.46%) Jun 29, 6:43PM EDT
    Add to Portfolio
    Prev Close:3.92
    Open:3.85
    Bid:3.60 x 400
    Ask:N/A
    1y Target Est:9.17
    Beta:3.88
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:3.60 - 3.88
    52wk Range:2.92 - 5.95
    Volume:5,264,435
    Avg Vol (3m):2,371,670
    Market Cap:431.20M
    P/E (ttm):N/A
    EPS (ttm):-0.69
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for XOMA

    Comparison

    Symbol% ChgMkt Cap
    XOMADown 6.63%431.20M
    NVSDown 1.39%238.48B
    REGNDown 3.01%53.15B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.51
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.64
    Quarterly EPS Est (Jun-15) :-0.18
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):-0.34

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback